SCHEMBL2453455

SCHEMBL2453455

CC(C)CCOc1c(Cl)cc(-c2csc(NC(=O)CBr)n2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 5/20 0.49
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ABL1 P00519 5/20 0.44
PI4KB Q9UBF8 1/20 0.43
CLK1 P49759 1/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
KMT2A Q03164 1/20 0.42
XIAP P98170 1/20 0.41
CYP3A4 P08684 1/20 0.40
ROCK1 Q13464 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480411 0.90 TRPA1 (0.58) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL2450859 0.89 TRPA1 (0.48) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL480870 0.88 TRPA1 (0.49) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL2450980 0.88 RAB9A (0.47) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL4407872 0.87 ABL1 (0.49) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL13570204 0.87 TRPA1 (0.47) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL2443035 0.86 MAPT (0.49) TRPA1MAPTLMNAMAPK1RAB9A
SCHEMBL2443409 0.85 ABL1 (0.47) TRPA1MAPTNPC1ALDH1A1LMNA
SCHEMBL10139184 0.84 TRPA1 (0.55) TRPA1MAPTABL1PI4KBCLK1
SCHEMBL610617 0.84 TRPA1 (0.60) TRPA1MAPTABL1PI4KBCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114184-A1 AMIDES OF HETEROCYCLIC COMPOUNDS AS TRPA1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-09-22 WO disclosed
WO-2009144548-A1 IMIDAZO [2,1-B] PURINE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2009-12-03 WO disclosed